Status:
COMPLETED
Transcend Auto vs Commercially Available Device Clinical Evaluation for Treatment of Obstructive Sleep Apnea (OSA)
Lead Sponsor:
Somnetics International, Inc.
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the Transcend Auto is as effective in treating obstructive sleep apnea as another device that is already on the market.
Detailed Description
This is a prospective, randomized, crossover trial. Patients will be randomized 1:1 to undergo two full night sleep studies with the Transcend Auto and a commercially available device.
Eligibility Criteria
Inclusion
- Adult 18 years of age or older
- Diagnosis of obstructive sleep apnea
- Presently using CPAP or APAP therapy
Exclusion
- Central or mixed apnea
Key Trial Info
Start Date :
February 27 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2013
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01799265
Start Date
February 27 2013
End Date
June 10 2013
Last Update
January 13 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwind Lung Specialists and Sleep Center
Coon Rapids, Minnesota, United States, 55433
2
Whitney Sleep Center
Plymouth, Minnesota, United States, 55441
3
Sleep Therapy and Research Center
San Antonio, Texas, United States, 78229